Active ingredientBambuterol HydrochlorideCat. No. P-B006-001CAS 81732-46-9Family · Pharmaceutical analytical standards
Bambuterol
A long-acting beta-2 agonist bronchodilator, patented in the early 1980s: it is taken by mouth as maintenance treatment for asthma. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.
Did you know?It is a prodrug: a blood enzyme, butyrylcholinesterase, slowly converts it into terbutaline, and the lung itself also concentrates and activates it. This is why its action lasts so long.
Go to the active ingredient →Active ingredientBambuterol HydrochlorideCat. No. P-B006-001CAS 81732-46-9
Pharmacopoeial impurityBambuterol EP Impurity BCat. No. P-B006-002CAS 112935-92-9
Pharmacopoeial impurityBambuterol EP Impurity C HClCat. No. P-B006-003CAS 81732-52-7
Pharmacopoeial impurityBambuterol EP Impurity DCat. No. P-B006-004CAS 112935-93-0
Pharmacopoeial impurityBambuterol EP Impurity ECat. No. P-B006-005CAS 81732-48-1
Pharmacopoeial impurityBambuterol EP Impurity F HClCat. No. P-B006-006CAS 2153431-91-3
NitrosamineN-Nitroso BambuterolCat. No. P-B006-007
ImpurityBambuterol Impurity 1Cat. No. P-B006-008CAS 1391921-22-4
ImpurityBambuterol Impurity 2Cat. No. P-B006-009CAS 81732-49-2
ImpurityBambuterol Impurity 3Cat. No. P-B006-011No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceBambuterol hydrochloride CRSEDQM code B0250000Family BambuterolNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.